← Evidence map

ArticleHemaSphere2026

Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real-world analysis from 20 US centers.

Allison M Bock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real-world analysis from 20 US centers. | OpenQuestion